Prevention programmes of progressive renal disease in developing nations

被引:52
作者
Codreanu, Igor
Perico, Norberto
Sharma, Sanjib K.
Schieppati, Arrigo
Remuzzi, Giuseppe
机构
[1] Osped Riuniti Bergamo, Mario Negri Inst Pharmacol Res, Dept Med & Transplantat, I-24125 Bergamo, Italy
[2] Republican Clin Hosp, Dept Hemodialysis & Kidney Transplantat, Kishinev, Moldova
[3] BP Koirala Inst Hlth Sci, Dept Med, Dharan, Nepal
关键词
cardiovascular diseases; emerging countries; prevention; renal diseases;
D O I
10.1111/j.1440-1797.2006.00587.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Development of strategies for the early detection and prevention of non-communicable diseases, including kidney disease, is the only realistic strategy to avert an imminent global health and economic crisis and enhance equity in health care worldwide. In this article, we briefly examine the burden of non-communicable diseases, including diabetes, hypertension, cardiovascular disease and how chronic kidney disease (CKD) represents a key integrated element in the setting, even in developing countries. A possible explanation of the increasing number of people who have or are at risk to develop CKD in poor countries is also given. A survey of major screening and intervention programmes performed or ongoing globally is then presented, highlighting differences and hurdles of projects planned in developed or developing nations as well as in unprivileged communities in developed countries. Finally, some recommendations on future steps to implement prevention programmes in emerging worlds are provided.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 62 条
  • [1] [Anonymous], 2003, The world health report 2003: shaping the future
  • [2] [Anonymous], 2002, World Health Report, 2002: Reducing risks, promoting healthy life
  • [3] Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
    Asselbergs, FW
    Diercks, GFH
    Hillege, HL
    van Boven, AJ
    Janssen, WMT
    Voors, AA
    de Zeeuw, D
    de Jong, PE
    van Veldhuisen, DJ
    van Gilst, WH
    [J]. CIRCULATION, 2004, 110 (18) : 2809 - 2816
  • [4] Overview: End-stage renal disease in the developing world
    Barsoum, RS
    [J]. ARTIFICIAL ORGANS, 2002, 26 (09) : 737 - 746
  • [5] Screening for proteinuria in US adults - A cost-effectiveness analysis
    Boulware, LE
    Jaar, BG
    Tarver-Carr, ME
    Brancati, FL
    Powe, NR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3101 - 3114
  • [6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [7] Bumgarner R, 2004, SOC PREV MED, V38, P202
  • [8] A nutrition paradox - Uderweight and obesity in developing countries
    Caballero, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) : 1514 - 1516
  • [9] *CAN I HLTH INF, 2001, DIAL REN TRANSPL CAN
  • [10] CAREL RS, 1987, CLIN CHEM, V33, P2106